CIB-RHR Publications and Presentations

PUBLICATIONS

Project 1: Dr. Tiffany Hensley-McBain (graduated as of 08/15/24)

Cook M, Aries M, Hensley-McBain T. A pilot study to investigate peripheral low level chronic LPS injection as a model of neutrophil activation in the periphery and brain in mice. Int J Mol Sci. 2024;25:5357. doi: 10.3390/ijms25105357

Laura Taylor, Adrian Borealis, Hensley-McBain T. Chapter 9: Strategies for Effective Laboratory Design in Medium-Maximum Security Penitentiaries. STEM Education in US Prisons. Lockard J, Mor T, eds. Brill; 2024. ISBN: 978-90-04-68864-3

Nemphos SM., Green HC., Prusak JE, Fell SL, Goff K, Varnado M, Didier K, Guy N, Moström MJ, Tatum C, Massey C, Barnes MB, Rowe LA, Allers C, Blair RV, Embers ME, Maness NJ, Marx PA,

Grasperge B, Kaur A, De Paris K, Shaffer JG, Hensley-McBain T, Londono-Renteria B, Manuzak JA. Elevated Inflammation Associated with Markers of Neutrophil Function and Gastrointestinal Disruption in Pilot Study of Plasmodium fragile Co-Infection of ART-Treated SIVmac239+ Rhesus Macaques. Viruses. 2024;16:1036 doi: 10.3390/v16071036.

Project 2: Dr. Mikael Klingeborn

Hernandez BJ, Skiba NP, Plössl K, Strain M, Liu Y, Grigsby D, Kelly U, Cady MA, Manocha V, Maminishkis A, Watkins T, Miller SS, Ashley-Koch A, Stamer WD, Weber BHF, Bowes Rickman C, Klingeborn M.Polarized Desmosome and Hemidesmosome Shedding via Small Extracellular Vesicles is an Early Indicator of Outer Blood-Retina Barrier Dysfunction. J Extracell Biol. 2023 Oct;2(10):e116. doi: 10.1002/jex2.116. Epub 2023 Oct 11. PMID: 38108061

Klingeborn, M. & Reese, Ed. Desmosome and Hemidesmosome Disassembly in Retinal Pigmented Epithelium – Intersection with the Exosome Pathway. Adv Exp Med Biol. 2024

Welsh J.A. et al. (2024) Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches J Extracell Vesicles. 13(2):e12404. doi: 10.1002/jev2.12404.

Mielke JK, Alam P, Klingeborn M, Schultz EP, Markham EL, Reese ED, Caughey B, Cashman NR, Leavens MJ(corresponding author). Seeding activity of Superoxide Dismutase 1 (SOD1) aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking induced conversion. Acta Neuropathologica (2024), 147(1):100. doi: 10.1007/s00401-024-02752-8.

Hanke-Gogokhia C, Zapadka TE, Finkelstein S, Klingeborn M, Maugel TK, Singer JH, Arshavsky VY, Demb JB.The structural and functional integrity of rod photoreceptor ribbon synapses depends on redundant actions of dynamins 1 and 3. J Neurosci. 2024 Apr 19:e1379232024. doi: 10.1523/JNEUROSCI.1379-23.2024. Online ahead of print. PMID: 38641407

Striebel JF*, Carroll JA, Race B, Leung JM, Schwartz C, Reese ED, Bowes Rickman C, Chesebro B & Klingeborn M.*The prion protein is required for normal responses to light stimuli by photoreceptors and bipolar cells. iScience 2024 In press.*Corresponding authors.

Project 3: Dr. Moses Leavens

Mielke JK, Alam P, Klingeborn M, Schultz EP, Markham EL, Reese ED, Caughey B, Cashman NR, Leavens MJ(corresponding author). Seeding activity of Superoxide Dismutase 1 (SOD1) aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues by real-time quaking induced conversion. Acta Neuropathologica (2024), 147(1):100. doi: 10.1007/s00401-024-02752-8.

Project 4: Dr. Andrea Grindeland

Grindeland, A. Global huntintin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas, Life Sci Alliance, July 2024. DOI: 10.26508/lsa.202402571

PRESENTATIONS

Project 1: Dr. Tiffany Hensley-McBain

 Hensley-McBain, T. MRI Research Public Outreach. McLaughlin Research Institute Open House, February 28, 2024.

 Brown, Rebecca; Hensley-McBain, Tiffany. Expanding access to clinical research in Montana. Masonic Temple. Great Falls, MT. March 4, 2024.

Presented to 20 members of the Masonic Temple about our efforts to expand Clinical Research and discussed the cohort study and the HERO registry. The presentation included why we need clinical research to translate findings and explained the benefits of clinical research to individuals and community.

 Aries, Michelle; Cook, Makayla; Gasvoda, Hope*; Gooman, Ashley*; Hensley-McBain, Tiffany. Genotype specific microbiome divergence of humanized APOE 2, 3, and 4 mice after microbiome standardization. The Allied Genetics Conference; Washington, DC. March 6, 2024.

 Aries, Michelle; Cook, Makayla; Gasvoda, Hope*; Gooman, Ashley*; Hensley-McBain, Tiffany. Genotype specific microbiome divergence of humanized APOE 2, 3, and 4 mice after microbiome standardization. The Allied Genetics Conference; Washington, DC. March 6, 2024.

Hensley-McBain, Tiffany. If we could turn back time: Studying inflammation and aging. Great Falls College Montana State University Night Out for Science, Great Falls, MT; March 23, 2024.

Hensley-McBain, T. MRI Research Public Outreach. Touro College of Osteopathic Medicine Montana Health Fair, Great Falls, MT. April 8, 2024.

Hensley-McBain, T. MRI Research Public Outreach. Montana State University Extension Agent Conference. April 24, 2024.

Aries, Michelle; Cook, Makayla; Gasvoda, Hope*; Gooman, Ashley*; Hensley-McBain, Tiffany. Genotype specific microbiome divergence of humanized APOE 2, 3, and 4 mice after microbiome standardization. Touro College of Osteopathic Medicine Montana Research Day. Great Falls, MT. May 6, 2024.

Hensley-McBain, Tiffany. Investigating and targeting inflammatory mechanisms of aging and age-related disease. Touro College of Osteopathic Medicine Montana Research Day. Great Falls, MT. May 6, 2024.

Kim, Mark*; Aries, Michelle; Tiffany Hensley-McBain. Synthesis of human recombinant ApoE protein to support future Alzheimer’s and neutrophil studies. Touro College of Osteopathic Medicine Montana Research Day. Great Falls, MT. May 6, 2024.

Presented keynote science presentation at fundraiser for local college to 150 community members. Presentation includes an explanation of how we use mouse models and human data to investigate aging and disease.

Hensley-McBain, T. Public Outreach. Great Falls Business Leader Breakfast, Great Falls, MT. May 21, 2024.

Hensley-McBain, T. Public Outreach. Department of Health and Human Services Local Health Department Call, June 12, 2024.

Aries, Michelle; Cook, Makayla; Gasvoda, Hope*; Gooman, Ashley*; Anna Perez*; Hensley-McBain, Tiffany. Genotype specific microbiome divergence of humanized APOE 2, 3, and 4 mice after microbiome standardization. Alzheimer’s Association International Conference, Philadelphia, PA; July 30 ,2024.

Hensley-McBain, Tiffany. Investigating inflammatory mechanisms of APOE4 in disease. Rocky Mountain Labs, Hamilton, MT; September 17, 2024.

Hensley-McBain, Tiffany. Project 1: Investigating neutrophilic inflammation as a therapeutic target in Alzheimer’s disease. CoBRE EAC Retreat. McLaughlin Research Institute, Great Falls, MT. September 24, 2024.

Hensley-McBain, Tiffany. Investigating neutrophilic inflammation as a therapeutic target in Alzheimer’s disease. McGlaughlin Research Institue. Great Falls, MT. October 11, 2024.

Hensley-McBain, Tiffany. Investigating neutrophilic inflammation as a therapeutic target in Alzheimer’s disease. Indian Family Health Clinic. November 18, 2024.

Project 2: Dr. Mikael Klingeborn

Klingeborn, M. Age-related Macular Degeneration. Presentation was made specifically to the public to increase awareness and understanding of our research at the Institute. McLaughlin Research Institute open house public presentations. McLaughlin Research Institute, Great Falls, MT. February 28-29, 2024.

Klingeborn, M. What are Induced Pluripotent Stem Cells. presentation for 160 students who toured the MRI, February 28-29, 2024.

Klingeborn, M. Age-related Macular Degeneration (AMD) – Potential novel treatments and diagnostic biomarkers. Big Sky Medical Science Seminar Series. University of Providence, Great Falls, MT. April 1, 2024.

Klingeborn, M. Age-related Macular Degeneration (AMD) – Potential Novel Treatments and Diagnostic Biomarkers. Big Sky Medical Science Seminar Series Public Presentation with 25 community members and 34 researchers in attendance at MSU – Great Falls College, April 24, 2024.

Klingeborn, M. Presentation about GEMMA core capabilities and services to M.J. Murdock Charitable Trust site visit on August 16, 2024.

Klingeborn, M. Modulation of exosome release for functional restoration in age-related retinal disorders. Joint Weissman/MRI/RML retreat. Rocky Mountain Laboratories, NIAID/NIH, Hamilton, MT. September 17, 2024.

Klingeborn, M. Age-related Macular Degeneration (AMD) – Potential Novel Treatments and Diagnostic Biomarkers. MRI 70th Anniversary Open House Tour with over 50 community members, September 23, 2024. 

Klingeborn, M. Project 2: Modulation of exosome release for functional restoration in age-related retinal disorders. CoBRE EAC Retreat. McLaughlin Research Institute, Great Falls, MT. September 24, 2024.

Klingeborn, M., Striebel J.F., Carroll J.A., Race B., Leung J.M., Schwartz C., Reese E.D., Bowes Rickman C. & Chesebro B. The Role of the Prion Protein in Retinal Function. International Society for Eye Research Biennial meeting (ISER2024). Buenos Aires, Argentina. October 21, 2024.

Project 3: Dr. Moses Leavens

Leavens, Moses and Mielke, Justin. Seeding activity of superoxide dismutase 1 aggregates in ALS and Parkinson’s disease. McLaughlin Research Institute community open house. Great Falls, MT. February 28-29, 2024.

Mielke, Justin and Leavens, Moses. Seeding activity of superoxide dismutase 1 aggregates in postmortem spinal cords from amyotrophic lateral sclerosis patients. Biophysical Society Meeting. Philadelphia, PA. February 10-14, 2024.

Leavens, Moses. Investigation of superoxide dismutase 1 in Parkinson’s disease. Big Sky Medical Science Seminar Series. University of Providence, Great Falls, MT. April 1, 2024.

Leavens, Moses. Seeding activity of superoxide dismutase 1 aggregates in familial and sporadic amyotrophic lateral sclerosis postmortem neural tissues. Protein Homeostasis in Health and Disease. Cold Spring Harbor, NY. April 24-28, 2024.

Reyes, Alex; Palose, Helan; Rodriguez, Claire; Leavens, Moses. Seeding activity of superoxide dismutase 1 aggregates in motor cortex and thoracic spinal cords from sporadic amyotrophic lateral sclerosis patients. Touro University Research Day. New York, NY. May 9, 2024.

2nd place poster, clinical and translational medicine category.

Leavens, Moses. Bridging the gap with Science, Technology, Engineering, Art, and Mathematics between the NIH Rocky Mountain Labs and Tribal communities. Montana Rocky Mountain Labs. NIH STEAM Collaborations with Indigenous Peoples Conference, Hamilton MT. August 2, 2024.

Leavens, Moses. Cu/Zn superoxide dismutase in age-related diseases: from pathological studies to developing new biomarkers. University of Montana Chemistry and Biochemistry seminar Missoula, MT. September 2024.

Leavens, Moses. SOD1 seeding activity is a cerebrospinal fluid biomarker for amyotrophic lateral sclerosis. Irv Weissman Montana Scientific Retreat MRI/RML retreat. Rocky Mountain Laboratories, NIAID/NIH, Hamilton, MT. September 17, 2024.

Sebogo, Mylene; Mielke, Justin; Leavens, Moses. SOD1 seeding activity is a cerebrospinal fluid biomarker for amyotrophic lateral sclerosis. Poster. 70th Anniversary and open house for McLaughlin Research Institute. Great Falls, MT. September 23, 2024.

Leavens, Moses. Project 3: Investigation of superoxide dismutase 1 in Parkinson’s disease. CoBRE EAC Retreat. McLaughlin Research Institute, Great Falls, MT. September 24, 2024.

Project 4: Dr. Andrea Grindeland

Grindeland, A. Genetic mouse models utilized to study CWD and other neurodegenerative diseases. Belt K-12 school science day; Belt, MT. February 19, 2024.

Middle school and science teachers attending increased awareness of genetic research potential in animal models and community awareness in research opportunities in MRI.

Grindeland, A. CWD studies in progress and human transmissibility potential. McLaughlin Research Institute community open house. Great Falls, MT. February 28, 2024.

Grindeland, A. Investigation into diseases, an interactive MRI experience. Student tours research day MRI Great Falls, MT.  February 28-29, 2024.

Middle school and high school students and teachers had interactive experience enabling exposure to scientific methods and equipment and opportunities for engagement with professional scientific staff.

Grindeland, A, & Canine, B. Research Spotlight: Chronic Wasting Disease. Big Sky Seminar Series Public Presentation. Providence University, Great Falls, MT. March 4, 2024.

Grindeland, A. CWD studies in Montana utilizing cervid and mouse models for innovative investigations. Leadership Montana meeting; MRI, Great Falls, MT. April 10, 2024.

*Shaaban D., Pounder J., Grindeland A. Assessing the impact of formic acid on brain tissues for prion inactivation (Poster). Touro COM-MT research day. Touro University, Great Falls, MT. May 6, 2024.

*Crew L., Pounder J., Grindeland A. Bridging the gap: Behavioral testing in mouse models for relevant insights into neurodegenerative diseases (Poster). Touro COM-MT research day. Touro University, Great Falls, MT. May 6, 2024.

Grindeland, A. and MRI staff. Comprehensive training for updated policies for safely working with biosafety level 2 and 2+ pathogens: Updated Prion SOP and staff biosafety training. MRI, Great Falls, MT. May 15, 2024.

Lian, Ansel; O'Moore, Jill; Cabin, Deborah E.; Grindeland, Andrea; Kordasiewicz, Holly; Zhao, Hien, T.; Vallabh, Sonia, M.; Minikel. Eric Vallabh. Dissecting the mechanism of prion disease-specific toxicity of antisense oligonucleotides using transcriptomics (Poster). RNA Therapeutics: From Concept to Clinic Conference. University of Massachusetts, Amherst, MA. June 26, 2024.

Grindeland, A. Introduction to research and career of the Grindeland laboratory. MRI student internship seminar series; Great Falls, MT. July 1, 2024.

High school and undergraduate level students from within MT and surrounding area.

*Grindeland, A, Clairissa Kaylor (Touro COM-MT 2027). Tips on strengthening applications to medical, veterinary, or graduate school. MRI student internship seminar series, Great Falls, MT. July 2, 2024.

*Grindeland, A, Havilagh Neujahr (University of Idaho graduate student). Montana wild cervid PRNP sequencing project. MRI Research In Progress; Great Falls, MT. July 24, 2024.

*Guter E. and Grindeland, A. Mouse models for investigation of neurodegenerative disease. MRI Summer Internship program, Great Falls, MT. August 2, 2024.

Grindeland, A. Chronic Wasting Disease investigations in mouse models. Irv Weissman Montana Scientific Retreat MRI/RML retreat. Rocky Mountain Laboratories, NIAID/NIH, Hamilton, MT. September 17, 2024.

*McElroy, S.; Greenwood C.; and Grindeland, A. Investigating CWD and human transmissibility. MRI Summer Internship program, Great Falls, MT. August 2, 2024.

*Shaaban D., Pounder J., Grindeland A. Assessing the impact of formic acid on brain tissues for prion inactivation (Poster). Touro COM-MT research day. Touro University, Great Falls, MT. September 23, 2024.

*Crew L., Pounder J., Grindeland A. Bridging the gap: Behavioral testing in mouse models for relevant insights into neurodegenerative diseases (Poster). Touro COM-MT research day. Touro University, Great Falls, MT. September 23, 2024.

Grindeland, A. Grindeland laboratory research overview and confocal microscope demonstration. The 70thAnniversary McLaughlin Research Institute. Great Falls, MT. September 23, 2024.

Grindeland, A. Project 4: Comprehensive phenotypic profiling of CWD to assess transmissibility and species barriers. CoBRE EAC Retreat. McLaughlin Research Institute, Great Falls, MT. September 24, 2024.

GEMMA Core (Publications and presentations may also be listed under RPLs)

Publications

Walker, WP, Ratz-Mitchem, ML, Wagner, K-U, Gunn, TM (2025) Neuronal deletion of Tumor Susceptibility Gene 101 causes rapid apoptotic loss of hippocampal CA3 neurons. Biomolecules (special issue on Molecular and Genetic Basis of Neurodegenerative Diseases), 15(6), 786. https://doi.org/10.3390/biom15060786

Elazar, D, Alvarez*, N, Drobeck*, S, Gunn, TM (2025) SLC1A4 and Serine Homeostasis: Implications for Neurodevelopmental and Neurodegenerative Disorders. Int J Mol Sci 26(5), 2104. Special issue on Neurodegenerative Disease: From Molecular Basis to Therapy, 3rd ed. PMID: 40076728. *Authors contributed equally.

Silvius, D, Hurley, E, Poitelon, Y, Wagner, KU, Feltri, ML, Gunn, TM (2025) Schwann cell deletion of Tumor Susceptibility Gene 101 (Tsg101) in mice results in severe peripheral neuropathy. MicroPubl Biol. 2025 Feb 21;2025:10.17912/micropub.biology.001406. doi: 10.17912/micropub.biology.001406. eCollection 2025.

Klingeborn, M, Arora, V, Chung, C, Donchenko, P, Wright, RN, Reese, ED, Gunn, TM (2025) Desmosome and Hemidesmosome Release via Exosomes from Retinal Pigmented Epithelium – A Precursor to Epithelial-Mesenchymal Transition in Early AMD? Curr Eye Res, 11:1-10. PMID: 40070018.

Dennaoui, R, Rädler, PD, Wicker, MN, Vistisen, K, Ferraiuolo, R-M, Triplett, AA, Shrestha, H, Liner, TA, Manthey, KC, Rui, H, Cardiff, RD, Gunn, TM, Perou, CM, Wagner, K-U (2025) Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma. Breast Cancer Research, 27(1):126. PMID: 40624726

Parashara, P, Gao, L, Riglos, A, Sidhu, S, Lartey, D, Marks, T, Williams, C, Siauw, G, Ostrem AIL, Siebold, C, Kinnebrew, M, Riffle, M, Gunn*, TM, Kong*, JH. The E3 ubiquitin ligase MGRN1 targets melanocortin receptors MC1R and MC4R via interactions with transmembrane adapters. *Co-corresponding authors. bioRxiv 2025.03.25.645338; doi: https://doi.org/10.1101/2025.03.25.645338 In revision for J Cell Science.

Tortuo, C, Du, A, Kerker, K, Gresack, J, DeGrave, C, Funk, K, Agnihortri, P, Hsieh, F, Gunn, TM, Ramboz, S, Bettencourt, B, Reich, S, Gao, G, Wang, D, Sah, DWY. Behavioral Efficacy of AAV FOXG1 Gene Replacement Therapy in a Mouse Model of FOXG1 Syndrome. bioRxiv 2025.04.02.646887; doi: https://doi.org/10.1101/2025.04.02.646887

Presentations

Gunn, T. Annual (IACUC) Refresher Training. MRI. Great Falls, MT. April 10, 2024.

Gunn, T. CRISPR-Cas9 gene editing and mouse behavior assessment. PEO Meeting. Great Falls, MT. May 16, 2024.

Mace, Allison. Research in Progress talk on DigiGait. MRI. Great Falls, MT. July 31, 2024.

Gunn, T. Progress update on GEMMA. CoBRE EAC Retreat. MRI Great Falls, MT. September 24, 2024.

Admin Core (Publications and presentations not listed under RPLs)

Publications:

Casey M, Zou D, Reijo Pera RA, Hensley-McBain T, Cabin DE. Alpha-synuclein null mutation exacerbates the phenotype of a model of Menkes disease in female mice. Front Neurosci. 2025 Jul 3;19:1613171. doi: 10.3389/fnins.2025.1613171. eCollection 2025.PMID: 40678754

Moukoudi Ndoko L, Zeszutek S, and Reijo Pera RA. (2025), Women’s health in rural American communities, J. Obstetrics Gynecology and Reproductive Sciences, 9(1) DOI:10.31579/2578-8965/253

Presentations:

Renee Reijo Pera, PhD, Keynote Speaker Address. Transcriptional regulation of germline genesis and neuronal fate: From development to disease. Annual Meeting of the American Society of Andrology (Testis Workshop). Denver, CO. May 3, 2024.

Renee Reijo Pera, PhD, Keynote Speaker Address. Alzheimer’s, Parkinson’s dementia expert to discuss brain harm, health. Public Outreach: NIAID (Rocky Mountain Laboratory) Hamilton, MT. January 12, 2024.

Renee Reijo Pera, PhD. Montana 10,000: A longitudinal study to understand suicide risk in Montana. Outreach to the Department of Public Health and Human Services, Montana Touro University, Great Falls, MT. January 25, 2024.

Renee Reijo Pera, PhD. Reproductive Physiology Guest Lecture and Research Talk to TouroCOM Students and Faculty Touro University, Great Falls, MT. February 21, 2024. 

Renee Reijo Pera, PhD. Science at the McLaughlin Research Institute Brief Research Talk to Approximately 30 Great Falls High School Students McLaughlin Research Institute, Great Falls, MT. February 28, 2024.

Renee Reijo Pera, PhD. Science at the McLaughlin Research Institute Brief Research Talk to Approximately 30 High School Students from CM Russell High School. McLaughlin Research Institute, Great Falls, MT. February 29, 2024.

Renee Reijo Pera, PhD. Science at the McLaughlin Research Institute. Brief Research Talk to Approximately 30 High School Students from Holy Spirit High. McLaughlin Research Institute, Great Falls, MT. February 29, 2024. 

Renee Reijo Pera, PhD. Science at the McLaughlin Research Institute in Great Falls, MT

Research Talk and Overview to Public Business Owners and Investors Montana Festival; Bozeman, MT. May 31, 2024.

Renee Reijo Pera, PhD. 70th Anniversary of the McLaughlin Research Institute

Brief History of Science at the MRI Open House at MRI; Great Falls, MT. September 23, 2024.

Renee Reijo Pera, PhD. 70th Anniversary of the McLaughlin Research Institute

Brief History of Science at the MRI. Celebration at TouroCOM; Great Falls, MT. September 23, 2024.

Renee Reijo Pera, PhD. CIB-RHR Administrative Core Update. CoBRE External Advisory Committee. MRI. Great Falls, MT. September 24, 2024.  

Dr. Amy Wisniewski, Eastern Oregon University, Behavioral Health Research in Montana, Challenges and Opportunities. MRI. Great Falls, MT. September 23, 2024.

Dr. Suzanne Phelan, Professor of Kinesiology & Public Health, California Polytechnic State University, Maternal Fetal Health and Obesity. MRI. Great Falls, MT. September 23, 2024.

Dr. Frank Bennett, Chief Scientific Officer at Ionis Pharmaceuticals and member of the Scientific Advisory Board at McLaughlin Research Institute, 1ON-717 - An Antisense drug for the treatment of Prion Disease. MRI. Great Falls, MT. September 23, 2024.

Dr. Miranda Orr, Associate Professor and Research Health Scientist at Wake Forest University School of Medicine, Bees Knees. MRI. Great Falls, MT. September 23, 2024.  

Montana Governor Greg Gianforte, Video Congratulations. MRI. Great Falls, MT. September 23, 2024.

Brett Slaughter, Natural Resource Liaison who covers Montana and field rep for Senator Daines, covering the Hi-Line of Montana and the Great Falls/Conrad area. Video by Senator Daines of congratulations. MRI. Great Falls, MT. September 23, 2024.

Montana Senator Jon Tester, Zoom meeting and congratulations. MRI. Great Falls, MT. September 23, 2024.

Dr. George Carlson, Director of McLaughlin Research Institute from 1988-2016. Zoom meeting and history of the MRI. MRI. Great Falls, MT. September 23, 2024.

Dr. Leroy Hood, Personalized Medicine. MRI. Great Falls, MT. September 23, 2024.

Dr. Irving Weissman, History of MRI and Hematopoiesis Research. MRI. Great Falls, MT. September 23, 2024.

Dr. Kaphil Bharti, Senior Investigator and Scientific Director of the Ocular and Stem Cell Translational Research Section at the National Eye Institute, Developing Functionally Authentic Retinal Pigment Epithelium Cells from Stem Cells. MRI. Great Falls, MT. September 23, 2024.  

Dr. Jefferson Kinney, Professor, Founding Chair of the Department of Brain Health, Reg Grundy and Joy Chambers-Grundy Chair for Brain Health, Co-Director, Pam Quirk Brain Health and Biomarker Laboratory, Alzheimer’s Disease and Biomarkers. MRI. Great Falls, MT. September 23, 2024.

Dr. Brent Race, Associate Scientist at Rocky Mountain Laboratories, Highlights of Chronic Wasting Disease Research at Rocky Mountain Laboratories. MRI. Great Falls, MT. May 2024.

Seminar Series (Presentations not listed under the RPLs)

Lorico, Aurelio. Extracellular trafficking and cell-to-cell communication. MRI. Great Falls, MT. March 19, 2024.

Orr, Miranda. Identifying, tracking, and therapeutically cleaning. MRI. Great Falls, MT. May 16, 2024.

Touchette-Valle, Edith. Postdoc talk: Increasing efficiency of detecting and analyzing NMR-based biomarkers of disease. MRI. Great Falls, MT. July 1, 2024.

Hosler, Ryan. Postdoc talk: Advancements in network intrusion detection and overview of interdisciplinary research. MRI. Great Falls, MT. July 10, 2024.

Bowes-Rickman, C., & Stamer, D. Duke University ARMD Talks. TouroCOM-MT Great Falls, MT. July 12, 2024.

Myers, C. B. Improvement & accountability: Leveraging the potential of program evaluation for CoBRE. MRI. Great Falls, MT. August 5, 2024.

Rudzitis, Christopher. Postdoc talk: Mechano-biochemical signaling integration: A new model of intraocular pressure dysregulation. MRI. Great Falls, MT. August 15, 2024.

Nuriel, Tal. investigate the physiological and pathological biology of apolipoprotein E ε4 (APOE4). MRI. Great Falls, MT. August 21, 2024.

Casey, MegAnne. Institutional History & Updates. Rotary Chapter Meeting. Great Falls, MT. August 20, 2024.

Mountain, R. Faculty candidate talk: Investigating the impact of psychosocial stress on skeletal health. MRI. Great Falls, MT. September 10, 2024.

Chittams-Miles, Alex. Postdoc talk: Nanosecond pulsed electric fields enhance MRSA susceptibility to clinically relevant antibiotics and trigger NLRP#-medicated immune activation. MRI. Great Falls, MT. September 12, 2024.

Sanders, Donna. Postdoc talk: Systematic anxiety screening in schools: A nurse led quality improvement project. MRI. Great Falls, MT October 6, 2024.